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Background: Cognitive fatigue and autonomic abnormalities are frequent symptoms 
in MS. Our model of MS-related fatigue assumes a shared neural network for cognitive 
fatigue and autonomic failures, i.e., aberrant vagus nerve activity induced by inflamma-
tory processes. Therefore, they should occur in common.
Objective: To explore the relationship between cognitive fatigue and autonomic symp-
toms in MS patients, using self-reported questionnaires.
Methods: In 95 MS patients, cognitive fatigue was assessed with the Fatigue Scale 
for Motor and Cognitive Functions and autonomic abnormalities with the Composite 
Autonomic Symptom Scale-31 (COMPASS-31). We used exploratory correlational anal-
yses and hierarchical regression analysis, controlling for age, depressive mood, disease 
status, and disease duration, to analyze the relation between autonomic abnormalities 
and cognitive fatigue.
results: The cognitive fatigue score strongly correlated with the COMPASS-31 score 
(r  =  0.47, p  <  0.001). Regression analysis revealed that a model, including the 
COMPASS-31 domains: pupillomotor, orthostatic intolerance, and bladder, best predict the 
level of cognitive fatigue (R2 = 0.47, p < 0.001) after forcing the covariates into the model.
conclusion: In MS patients, cognitive fatigue and autonomic dysfunction share a pro-
portion of variance. This supports our model assuming that fatigue might be explained 
at least partially by inflammation-induced vagus nerve activity.
Keywords: multiple sclerosis, cognitive fatigue, Fatigue scale for Motor and cognitive Functions, autonomic 
failures, cOMPass-31, vagus nerve, inflammation
inTrODUcTiOn
Fatigue and autonomic abnormalities, such as cardiovascular or bladder dysfunctions, are frequent 
symptoms in multiple sclerosis decreasing a patient’s quality of life. Both, fatigue and autonomic 
abnormalities, occur in early stages of MS and some studies reported an association between fatigue 
and autonomic abnormalities in MS patients which might indicate a common pathological mecha-
nism underlying these symptoms (1–5).
Abbreviations: BDI, Beck’s Depression Inventory; CIS, clinically isolated syndrome; COMPASS-31, Composite Autonomic 
Symptom Scale-31; EDSS, Expanded Disability Status Scale; FSMC, Fatigue Scale for Motor and Cognitive Functions.
TaBle 1 | Data of the complete drop outs.
Drop outs
Number (n) 11
Agea 54.10 ± 11.46
Gender (male:female) 3:7
EDSS scorea 4.6 ± 2.28
Disease course pp MS: 3 rr MS: 5 sp MS: 2
aMean ± SD.
EDSS, Expanded Disability Status Scale; n, number; pp, primary progressive; rr, 
relapsing–remitting; sp, secondary progressive; MS, multiple sclerosis.
FigUre 1 | Drop out flow chart. *1Eight participants did drop out immediately 
due to early departure (n = 8), missing data of the COMPASS (n = 2) and the 
Fatigue Scale for Motor and Cognitive Functions (n = 1) due to not being 
consent to answer single questions out of personal reasons.*2Drop out due to 
missing data about disease duration (n = 3; no clear date in personal medical 
history), Expanded Disability Status Scale (n = 2; not assessed by the 
medical staff) and Beck Depression Inventory Scale (n = 2; no consent to 
complete this questionnaire).
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Recently, Hanken et al. (6) developed a model for explaining 
fatigue in MS patients. According to this model, increased bodily 
inflammation plays a major role in the generation of MS-related 
fatigue. It assumes that proinflammatory cytokines activate the 
afferents of the vagus nerve which convey information about 
bodily inflammation to interoceptive brain areas, such as the 
nucleus tractus solitarius, the hypothalamus, the insular cortex, 
the anterior cingulate cortex, and the amygdala. According to 
the model, this inflammation-induced activity in interoceptive 
brain areas also is associated with the generation of the feeling of 
fatigue in MS patients. It should be noted that apart from this 
model, there are other models trying to explain the emergence of 
cognitive fatigue differently, but we will focus on this model in the 
following way: trying to find underpinning aspects.
The nervous structures that play an important role in the model 
of MS-related fatigue such as the vagus nerve and interoceptive 
brain areas also are considered to be the main components of 
the autonomic nervous system (7). Interoceptive brain areas 
integrate visceral sensory information and regulate autonomic 
functions, whereas efferents of the vagus nerve form a major 
component of the parasympathetic nervous system control-
ling several autonomic functions. Moreover, proinflammatory 
cytokines are considered to have an influence on the control of 
autonomic functioning (8, 9) as they activate the afferent vagus 
nerve that subsequently activates efferents of the vagus nerve. 
This might result in parasymapathetic overactivity causing a 
disruption of autonomic control. Those autonomic functions that 
are under direct control of the efferent vagus nerve should be 
mostly disrupted by this overactivity (9).
Hence, we assume that common pathological mechanisms, 
such as chronic peripheral inflammation and a resulting over-
activity of the vagus nerve, generate fatigue as well as autonomic 
abnormalities in MS patients.
The aim of this study was to explore the relationship between 
subjective cognitive fatigue and the global amount of self-
reported autonomic abnormalities in MS patients. Moreover, 
we wanted to investigate which autonomic abnormalities best 
predict the level of MS-related cognitive fatigue.
MaTerials anD MeThODs
106 MS patients with a relapsing–remitting (rr MS; 57%), a 
secondary progressive (sp MS; 22%), or a primary progressive 
(pp MS; 21%) disease course according to the McDonald criteria 
(10) participated in this study lasting from May 2016 to June 2017. 
11 participants did drop out in analyses due to early departure 
and three due to missing answers in the Composite Autonomic 
Symptom Scale-31 (COMPASS-31) or the Fatigue Scale for Motor 
and Cognitive Functions (FSMC). Additional seven participants 
did drop out due to missing data of disease duration, Expanded 
Disability Status Scale (EDSS), and Beck Depression Inventory 
Scale (BDI) (see Figure 1 and Table 1).
Patients have been inpatients of the Rehabilitation Center 
Wilhelmshaven, Wilhelmshaven, Germany and were inter-
viewed at the beginning of their rehabilitation program. Indi-
viduals with a MS relapse or using corticosteroids during the last 
4 weeks, under legal care and/or with a diagnosis of any other 
neurodegenerative disease were excluded from the study. The 
study was approved by the ethical board of the Medical Society 
in Bremen and written informed consent was obtained from 
participants.
To assess the level of subjective cognitive fatigue, we used 
the cognitive fatigue subscore of the FSMC (11). The FSMC is a 
self-report questionnaire consisting of 20 questions of which 10 
questions assess the severity of cognitive fatigue. The cognitive 
fatigue subscore ranges from 10 to 50 and a score higher or equal 
to 28 indicates moderate cognitive fatigue. To assess the severity 
TaBle 3 | Data of study group separated according to the presence of cognitive 
fatigue.
no cognitive 
fatigue (FsMc 
cognition ≤22)
cognitive  
fatigue (FsMc 
cognition ≥22)
Number (n) 20 75
Gender (male:female) 8:12 28:47
Agea 48.15 ± 10.74 49.46 ± 9.99
Disease duration (years)a 9.56 ± 8.01 13.56 ± 9.95
EDSS scorea 3.08 ± 2.30 4.03 ± 2.28
Cognitive fatigue subscore of the FSMCa 16.85 ± 2.90 35.36 ± 7.20
BDI total scorea 2.75 ± 2.30 6.39 ± 3.41
COMPASS-31 scorea 12.70 ± 12.08 23.63 ± 10.25
Orthostatic intolerance subscore 
COMPASS-31a
2.50 ± 3.05 5.08 ± 2.91
Vasomotor subscore COMPASS-31a 0.70 ± 1.50 1.25 ± 1.59
Secretomotor subscore COMPASS-31a 1.05 ± 1.57 1.60 ± 1.69
Gastrointestinal subscore COMPASS-31a 4.10 ± 4.80 6.73 ± 5.10
Bladder subscore COMPASS-31a 1.40 ± 2.09 3.05 ± 2.44
Pupillomotor subscore COMPASS-31a 2.95 ± 3.59 5.91 ± 3.47
aMean ± SD.
BDI, Beck Depression Inventory; COMPASS-31, Composite Autonomic Symptom 
Scale-31; EDSS, Expanded Disability Status Scale; FSMC, Fatigue Scale for Motor  
and Cognitive Functions; n, number.
TaBle 2 | Data of the study group.
Ms study group
Number (n) 95
Gender (male:female) 30:65
Agea 49.17 ± 10.1
Disease duration (years)a 12.7 ± 9.7
EDSS scorea 3.8 ± 2.3
Cognitive fatigue subscore of the FSMCa 31.5 ± 10.0
BDI total scorea 11.3 ± 6.4
COMPASS-31 scorea 21.3 ± 11.5
Orthostatic intolerance subscore COMPASS-31a 4.5 ± 3.1
Vasomotor subscore COMPASS-31a 1.1 ± 1.6
Secretomotor subscore COMPASS-31a 1.5 ± 1.7
Gastrointestinal subscore COMPASS-31a 6.2 ± 5.1
Bladder subscore COMPASS-31a 2.7 ± 2.5
Pupillomotor subscore COMPASS-31a 5.3 ± 3.7
Disease modifying treatment None: 54
Natalizumab: 4
Galtirameracetate: 3
Fingolimod: 3
Interferon-beta: 13
Teriflunomide: 8
Dimethylfumarate: 9
Mitoxantrone: 1
Spasmolytics (Fampyra or Baclofen) 20
aMean ± SD.
BDI, Beck Depression Inventory; COMPASS-31, Composite Autonomic Symptom 
Scale-31; EDSS, Expanded Disability Status Scale; FSMC, Fatigue Scale for Motor and 
Cognitive Functions; n, number.
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of autonomic symptoms, we used the COMPASS-31, consisting 
of 31 questions (12). The questions assess the severity of auto-
nomic symptoms in six different domains, including orthostatic 
intolerance, vasomotor, secretomotor, gastrointestinal, bladder, 
and pupillomotor activity. The total score ranges from 0 to 100, 
with higher scores reflecting more severe autonomic dysfunc-
tions (cutoff value 32.5). In addition, the severity of depressive 
symptoms was assessed using the BDI (13). We used the items 
A-O, the mental items, to calculate the score for mood impair-
ment, whereas the P-U items (sleep, tiredness, body weight, loss 
of sexual interest, and somatic concerns) reflect the somatic score.
Exploratory (Spearman correlation) and partial correlational 
analyses were performed to investigate the relation between 
cognitive fatigue, autonomic dysfunctions, and clinical data.
Hierarchical multiple regression analysis was used to analyze 
the prediction of cognitive fatigue status on the basis of autonomic 
dysfunctions. In a first step, the variables age, disease duration 
(time since first diagnosis), EDSS, and the mental BDI score 
were included in the regression analysis as control variables. In a 
second step, we added the autonomic domain scores (orthostatic 
intolerance, vasomotor, secretomotor, gastrointestinal, bladder, 
and pupillomotor domain score) to see if and which of them 
would improve the prediction. For this second block, forward 
regression analysis was used.
To check for the influence of autonomic disturbances on 
motor fatigue, the same regression analysis was performed with 
the motor fatigue subscore of the FSMC as dependent variable.
Furthermore, we checked for differences between the rr MS, 
sp MS, and pp MS patients in the cognitive score of the FSMC 
and the scales of the COMPASS-31 using one-way ANOVA and 
Kruskal–Wallis H test, respectively.
resUlTs
95 patients (male:female ratio =  30:65; mean age =  49; 57.6% 
rr MS; 22.8% sp MS; 19.6% pp MS) provided responses to all 
items of the FSMC and the COMPASS-31. These patients had a 
mean disease duration of 13 years and a mean EDSS score of four. 
Overall, 66% of patients presented a cognitive fatigue subscore 
equal or above 28 indicating moderate cognitive fatigue, 17% 
presented autonomic abnormalities (COMPASS-31 score equal 
or higher to 32.5) and 32% showed signs of depression (BDI equal 
or higher to 14; see Tables 2 and 3).
Due to the heterogeneity of the patient group, we checked 
for differences between the rr MS, sp MS, and pp MS patients 
on the cognitive score of the FSMC, and the scales of the 
COMPASS-31 using one-way ANOVA and Kruskal–Wallis H 
test, respectively (see also Table  4). We found no significant 
difference between groups for the cognitive Fatigue Scale of the 
FSMC, the COMPASS-31 total score, and its subscores apart from 
the gastrointestinal subscore [χ2(2) =  7.86, p =  0.020] and the 
bladder subscore [χ2(2) = 11.85, p = 0.003]. Dunn–Bonferroni 
post hoc tests revealed that the rr MS and the sp MS patients dif-
fered significantly in the gastrointestinal subscore (rr MS: mean 
rank 44.83; sp MS mean rank: 60.91; z = −2.77, p = 0.005) and 
bladder subscore (rr MS: mean rank 39.06; sp MS mean rank: 
61.07; z = −3.26, p = 0.003).
The results of the exploratory correlational analyses showed 
no correlation of the cognitive fatigue subscore with age, dis-
ease duration, or the level of disability. Also, the total score of 
the COMPASS-31 did not correlate with age, disease duration, 
or the level of disability. Concerning the domain subscores of 
the COMPASS-31, the bladder domain subscore significantly 
FigUre 2 | Correlation between the cognitive fatigue subscore of the Fatigue Scale for Cognitive and Motor Functions and the total score of the Composite 
Autonomic Symptom Scale-31, assessed in 95 MS patients.
TaBle 4 | Data of study group separated according to the disease course.
rr Ms sp Ms pp Ms 
Number (n) 53 21 18
Gender (male:female) 20:33 11:10 4:14
Agea 45.71 ± 8.88 54.19 ± 9.55 54.67 ± 8.36
Disease duration (years)a 10.94 ± 8.73 19.95 ± 8.87 10.44 ± 9.78
EDSS scorea 2.87 ± 1.96 5.67 ± 1.73 4.83 ± 2.11
Cognitive fatigue subscore 
of the FSMCa
31.79 ± 10.61 33.00 ± 8.73 29.72 ± 9.35
BDI total scorea 10.80 ± 5.64 12.57 ± 6.28 11.75 ± 8.09
COMPASS-31 scorea 19.83 ± 11.87 24.57 ± 11.47 21.95 ± 8.88
Orthostatic intolerance 
subscore COMPASS-31a
4.53 ± 3.15 4.48 ± 3.12 4.72 ± 3.08
Vasomotor subscore 
COMPASS-31a
0.98 ± 1.51 1.33 ± 1.80 1.22 ± 1.55
Secretomotor subscore 
COMPASS-31a
1.32 ± 1.73 2.19 ± 1.72 1.22 ± 1.34
Gastrointestinal subscore 
COMPASS-31a
5.30 ± 4.86 8.43 ± 4.77 6.06 ± 5.64
Bladder subscore 
COMPASS-31a
2.11 ± 2.30 3.91 ± 2.45 3.22 ± 2.39
Pupillomotor subscore 
COMPASS-31a
5.58 ± 3.76 4.23 ± 3.10 5.50 ± 3.79
aMean ± SD.
BDI, Beck Depression Inventory; COMPASS-31, Composite Autonomic Symptom 
Scale-31; EDSS, Expanded Disability Status Scale; FSMC, Fatigue Scale for Motor and 
Cognitive Functions; n, number.
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correlated with age (r  =  0.38, p  <  0.001), disease duration 
(r = 0.29, p = 0.003), and the level of disability (r = 0.47, p < 0.001). 
The gastrointestinal and the pupillomotor domain subscores 
significantly correlated with the EDSS score (r = 0.29, p = 0.002; 
r = −0.27, p = 0.005).
We found a strong positive correlation of the cognitive fatigue 
subscore with the total COMPASS-31 score (r = 0.47, p < 0.001; 
see Figure 1). Furthermore, the level of cognitive fatigue as well 
as the total COMPASS-31 score correlated with the mental BDI 
subscore (cognitive fatigue: r =  0.45, p <  0.001; Compass-31: 
r =  0.49, p <  0.001). When controlling for mental BDI score, 
the correlation of the cognitive fatigue subscore with the total 
COMPASS-31 score remained highly significant (r  =  0.40; 
p < 0.001).
Furthermore, the partial correlation analysis (controlling for 
mental BDI score) revealed positive correlations of the cognitive 
fatigue subscore with the pupillomotor (r = 0.39; p < 0.001), the 
orthostatic intolerance (r =  0.37; p <  0.001), and the bladder 
domain subscore (r = 0.23; p = 0.013; see Figures 2–5).
88 patients provided responses to all items considered in 
the regression analysis. The results of the forward regression 
analysis controlling for age, disease duration, EDSS, and mental 
BDI score revealed that the mental BDI score, the pupillomo-
tor, the orthostatic intolerance, and the bladder domain of the 
COMPASS-31 were described as significant predictors for the 
cognitive fatigue score (see Table  5). The model describes a 
significant percentage of the variance of the level of cognitive 
fatigue (R2 = 0.47, F = 10.45, p < 0.001). This model describes 
much more of the variance (R2 = 0.47) than the model, including 
the control variables only (R2 = 0.26).
The regression analysis for the motor fatigue subscore as 
dependent variable showed that the mental BDI score (beta 
FigUre 3 | Correlation between the cognitive fatigue subscore of the Fatigue Scale for Cognitive and Motor Functions and the pupillomotor domain score of the 
Composite Autonomic Symptom Scale-31, assessed in 95 MS patients.
FigUre 4 | Correlation between the cognitive fatigue subscore of the Fatigue Scale for Cognitive and Motor Functions and the orthostatic domain score of the 
Composite Autonomic Symptom Scale-31, assessed in 95 MS patients.
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coefficient  =  0.39, p  <  0.001), the pupillomotor (beta coef-
ficient =  0.24, p =  0.18), and orthostatic domain score (beta 
coefficient = 0.20, p = 0.04) of the COMPASS-31 best predicted 
the level of motor fatigue in MS patients (R2 =  0.41, F =  9.61, 
p < 0.001).
DiscUssiOn
The results of this study point to a strong relationship between 
subjective cognitive fatigue (the experienced cognitive fatigue 
reported by questionnaires without objective measures) and 
autonomic abnormalities in MS patients. Especially, autonomic 
abnormalities, such as pupillomotor dysfunctions, orthostatic 
intolerance, and bladder dysfunctions, appear to be related to 
cognitive fatigue in MS patients. The strong relationship between 
cognitive fatigue and autonomic abnormalities might indicate 
that common pathological mechanisms are involved in cognitive 
fatigue and autonomic dysregulations in MS patients.
Concerning the relationship between fatigue and autonomic 
dysfunctions, particularly orthostatic intolerance seems to be 
related to fatigue in MS patients. Flachenecker and colleagues (3) 
examined heart rate variability of 60 MS patients during standard 
autonomic function tests and found that autonomic responses 
correlated with fatigue resembling a hypoadrenergic orthostatic 
response. Lebre et al. (4) investigated 50 rr MS patients and found 
that especially patients with fatigue present a loss in the capacity to 
increase blood pressure. Kanjwal and colleagues (14) investigated 
nine MS patients with postural orthostatic tachycardia syndrome 
and found that this syndrome was strongly related to fatigue 
and that treatment of postural orthostatic tachycardia resulted 
in a reduction of fatigue in the majority of investigated patients. 
Similar to our results, Cortez and colleagues (1) found a correla-
tion between self-reported fatigue and autonomic symptoms in 
MS patients. Their results also pointed to a particular relation 
between fatigue and orthostatic intolerance in MS patients.
FigUre 5 | Correlation between the cognitive fatigue subscore of the Fatigue Scale for Cognitive and Motor Functions and the bladder domain score of the 
Composite Autonomic Symptom Scale-31, assessed in 95 MS patients.
TaBle 5 | Results of the model best predicting the cognitive fatigue score.
standardized coefficient beta t p
(Constant) 5.186 0.000
Age −0.178 −1.830 0.071
Disease duration 0.120 1.339 0.184
EDSS −0.020 −0.186 0.853
Mental BDI score 0.307 3.363 0.001
Pupillomotor domain score 0.242 2.399 0.019
Orthostatic domain score 0.273 2.997 0.004
Bladder domain score 0.201 2.060 0.043
Dependent variable: cognitive fatigue score of the Fatigue Scale for Motor and 
Cognitive Functions.
Control variables: age, disease duration.
EDSS, Expanded Disability Status Scale; mental Beck Depression Inventory Scale  
(BDI) score.
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Bladder dysfunctions are the most common autonomic 
disturbances in MS (15). Most common urodynamic symptoms 
are nocturia, urinary urgency, and frequency (16). Urinary 
symptoms are correlated with disability status and considered to 
be related to spinal cord lesions or lesions in cortical regions that 
control urinary tract regulation (medial prefrontal cortex, insula, 
and pons) (17). Nevertheless, urinary symptoms, such as detrusor 
overactivity, detrusor-sphincter dyssynergia are already present 
in early MS stages and have been observed in several patients at 
the level of clinically isolated syndrome (CIS) (18). This might 
indicate that also other mechanisms than demyelination and atro-
phy contribute to these symptoms, especially in these early stages.
The same holds for pupillomotor dysfunctions. Pupillary dis-
turbances such as abnormal pupillary light reflex latencies and 
abnormal contraction amplitudes have been frequently observed 
in early stages of MS (19–21), pointing to other mechanisms than 
increased demyelination and brain atrophy in the generation of 
these disturbances.
We found that autonomic symptoms, such as pupillomotor 
dysfunction, orthostatic intolerance, and bladder dysfunction, 
best predict the level of cognitive fatigue in MS patients. Since we 
included the variables disease duration and EDSS in the regres-
sion analysis, the results indicate that autonomic dysfunctions 
have a negative influence on the manifestation of cognitive fatigue 
independent of disease duration and progression. Furthermore, 
we included the mental BDI score in the regression analysis. 
Hence, it seems unlikely that the obtained results arise from a 
simple “over-reporting” of symptoms.
Overall, fatigue and autonomic abnormalities have been fre-
quently described early in the disease course of MS (18, 20, 22). 
Already at the stage of a CIS and in very early MS stages, 
patients may present fatigue, bladder dysfunctions, and pupil-
lary abnormalities (18, 20, 21, 23). During these early stages, 
neurological impairment is usually very limited and hardly any 
structural changes in the central nervous system have occurred 
yet. Consequently, factors such as increased brain atrophy, 
advanced disability, or increased age can be excluded as possible 
causes for fatigue and autonomic abnormalities in such early 
stages. However, very early stages of MS seem to reflect the same 
full-blown pattern of immunological abnormalities that is seen 
in later disease stages, highlighting the potential role of increased 
proinflammatory cytokines in the generation of subjective fatigue 
and autonomic abnormalities in MS patients (24).
Hanken et al. (6) developed a model of MS-related fatigue, based 
on all sorts of data. According to this model, the increased level 
of peripheral proinflammatory cytokines activates afferents of the 
vagus nerve that convey information about bodily inflammation 
to the central nervous system. This increased inflammation- 
induced activity of the afferent vagus nerve results in an increased 
activity in interoceptive brain areas and subsequently increases 
activity of the efferent vagus nerve. The increased activity in 
interoceptive brain areas might generate the feeling of fatigue, 
whereas the increased activity of the efferent vagus nerve that 
mainly contribute to the parasympathetic nervous system might 
lead to disruptions in autonomic functioning, whereas particu-
larly those functions should be affected that are under direct 
control of the efferent vagus nerve.
Parasympathetic overactivity and resulting impaired sympa-
thetic-mediated control might cause a reduction in blood pres-
sure resulting in orthostatic intolerance, an increased promotion 
in voiding resulting in bladder dysfunction, and a constriction of 
the pupil resulting in problems with focusing.
The fact that the correlation between cognitive fatigue, on the 
one hand, and secretomotor and vasomotor symptoms, on the 
other hand, was not significant might be due to the fact that these 
functions are not completely under the control of the efferent 
vagus nerve. Sudomotor and vasomotor processes, for example, 
are only controlled by the sympathetic branch (25). Therefore, 
it is interesting that these two symptoms did not remain in 
the regression analysis, whereas the three autonomic function 
failures, which contributed to the prediction of fatigue level, are 
all influenced by the parasympathetic branch of the autonomic 
nervous system. This finding fits well with our model. The 
gastrointestinal domain stands under a complex homeostatic 
regulation, with inhibitory as well as excitatory parasympathetic 
nervous control, which might explain the lack of a correlation 
between this domain and the cognitive fatigue score (25). With 
respect to the bladder and gastrointestinal functions, the only 
autonomic function failures that differed between rr MS and 
sp MS, it should be noted that spinal lesions, among other fac-
tors, might also impair autonomic functions and that axons for 
bladder (and gastrointestinal) control travel through almost 
the entire spinal cord. Therefore, the chance of suffering spinal 
lesions during the disease development is much higher for these 
functions than for other autonomic functions. However, a more 
detailed mapping of specific autonomic nervous dysfunctions 
on cognitive fatigue would be highly speculative and cannot be 
answered by our data.
Assuming that systemic inflammation causes fatigue and 
autonomic dysfunctioning in MS patients, anti-inflammatory 
approaches such as IL-1β antagonists might reduce vagus nerve 
signaling and may, consequently, result in a reduction of fatigue 
and autonomic abnormalities (9). Consequently, IL-1β antago-
nists point to a completely new path for the treatment of fatigue. 
However, this assumption is rather speculative and more studies 
investigating the relation between fatigue, autonomic dysfunc-
tions, and inflammation are needed to clarify this possibility.
A limitation of this study is that only questionnaires were used 
to investigate fatigue and autonomic functions. Objective meas-
ures of autonomic functions and cognitive fatigue are necessary to 
analyze the exact relationship between these symptoms. To check 
for the involvement of proinflammatory cytokines in the gen-
eration of these symptoms, blood investigations combined with 
fatigue and autonomic function measures need to be performed. 
Moreover, the COMPASS-31 does not cover the assessment of the 
complete range of autonomic symptoms. Abnormalities in sexual 
functions or thermoregulatory functions are not addressed by 
the questionnaire. MS patients often report sexual dysfunctions, 
such as sexual arousal disorders in women, erectile dysfunction 
in men, orgasmic dysfunction and dyspareunia. These dysfunc-
tions also seem to be associated with MS-related fatigue (26). In 
addition, studies demonstrated an elevated body temperature in 
fatigued MS patients, pointing to thermoregulatory abnormali-
ties in fatigued MS patients (27, 28). Hence, abnormalities within 
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these autonomic functions should also be addressed to get a 
com plete overview of the relation between autonomic functions 
and fatigue in MS patients.
It should be mentioned that this is not the only possible expla-
nation for the occurrence of cognitive fatigue in MS. There are 
many causes besides autonomic functions but even when control-
ling for age, disease duration, and EDSS relations to autonomic 
functions remained in the model. Discussing all possible causes 
would be highly speculative and, therefore, we focus on the above 
named model.
Furthermore, it should be noted that our patient group was 
a mixed cohort, including patients suffering from rr MS, sp MS, 
and pp MS. As there might be different underlying pathological 
mechanisms for these three types, we still think that it is a repre-
sentative patient group because in all of them inflammation plays 
a more or less central role (29).
In conclusion, we found a strong correlation between subjec-
tive feelings of cognitive fatigue and autonomic abnormalities in 
MS patients. Particularly, pupillomotor abnormalities, orthos-
tatic intolerance, and bladder dysfunctions were correlated with 
cognitive fatigue, pointing to a common pathological mechanism 
in the generation of autonomic abnormalities and cognitive 
fatigue in MS.
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